Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Arch Capital
ACGL
$33.5B
| $43.3M | 0.01% |
1,135,193
-5,930
| -0.5% | -$235K |
|
977
AGNC Investment
AGNC
$13B
| $43.2M | 0.01% |
2,741,355
+111,085
| +4% | +$1.8M |
|
|
FYBR
978
DELISTED
Frontier Communications
FYBR
| $43.2M | 0.01% |
+1,549,653
| New | +$46.1M |
|
979
Vontier
VNT
$4.52B
| $43.1M | 0.01% |
1,283,001
+32,166
| +3% | +$1.09M |
|
980
Glacier Bancorp
GBCI
$6.42B
| $42.9M | 0.01% |
775,483
-25,569
| -3% | -$1.35M |
|
981
Gentex
GNTX
$4.94B
| $42.9M | 0.01% |
1,300,895
-233,934
| -15% | -$7.55M |
|
982
Ambarella
AMBA
$3.65B
| $42.8M | 0.01% |
274,815
-1,478
| -0.5% | -$170K |
|
983
Herc Holdings
HRI
$5.62B
| $42.7M | 0.01% |
261,161
-7,206
| -3% | -$913K |
|
|
ETRN
984
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $42.6M | 0.01% |
4,199,919
-525,014
| -11% | -$4.63M |
|
985
Acadia Healthcare
ACHC
$2.97B
| $42.5M | 0.01% |
667,022
-1,780
| -0.3% | -$112K |
|
986
PG&E
PCG
$38.1B
| $42.5M | 0.01% |
4,426,581
-154,112
| -3% | -$1.45M |
|
987
Reinsurance Group of America
RGA
$16.1B
| $42.4M | 0.01% |
381,160
+11,367
| +3% | +$1.29M |
|
|
AL
988
DELISTED
Air Lease Corp
AL
| $42.4M | 0.01% |
1,077,847
+5,888
| +0.5% | +$240K |
|
989
Hilton Grand Vacations
HGV
$3.46B
| $42.4M | 0.01% |
890,575
+47,599
| +6% | +$2.02M |
|
990
NeoGenomics
NEO
$2.1B
| $42.4M | 0.01% |
878,049
+31,631
| +4% | +$1.46M |
|
991
SLM Corp
SLM
$5.22B
| $42.4M | 0.01% |
2,406,252
-113,350
| -4% | -$2.13M |
|
992
Euronet Worldwide
EEFT
$2.61B
| $42.3M | 0.01% |
332,609
+15,053
| +5% | +$2M |
|
|
EQC
993
DELISTED
Equity Commonwealth
EQC
| $42.3M | 0.01% |
1,627,222
-204,993
| -11% | -$5.39M |
|
994
Integra LifeSciences
IART
$1.34B
| $42.2M | 0.01% |
616,623
+30,154
| +5% | +$2.13M |
|
995
XPO
XPO
$24.6B
| $42.1M | 0.01% |
891,002
-747,979
| -46% | -$37.5M |
|
996
Novanta
NOVT
$6.36B
| $42.1M | 0.01% |
272,541
+7,613
| +3% | +$1.11M |
|
|
SRCL
997
DELISTED
Stericycle Inc
SRCL
| $42.1M | 0.01% |
618,937
+31,639
| +5% | +$2.19M |
|
998
Avient
AVNT
$4.14B
| $42.1M | 0.01% |
907,566
+1,098
| +0.1% | +$52.7K |
|
999
Globus Medical
GMED
$11.3B
| $41.7M | 0.01% |
544,688
+51,048
| +10% | +$4.1M |
|
1000
SouthState Bank Corp
SSB
$10.7B
| $41.7M | 0.01% |
558,779
-17,266
| -3% | -$1.23M |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.